Cargando…

Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review

Definitive pharmacological therapies for COVID-19 have yet to be identified. Several hundred trials are ongoing globally in the hope of a solution. However, nearly all treatments rely on systemic delivery but COVID-19 damages the lungs preferentially. The use of a targeted delivery approach is revie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kipshidze, Nicholas, Iversen, Patrick, Porter, Thomas R., Kipshidze, Nodar, Siddiqui, Fakiha, Dangas, George, Fareed, Jawed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498969/ https://www.ncbi.nlm.nih.gov/pubmed/32936689 http://dx.doi.org/10.1177/1076029620954911

Ejemplares similares

A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™
por: Iversen, Patrick L., et al.
Publicado: (2023)

Viral Coagulopathy in Patients With COVID-19: Treatment and Care
por: Kipshidze, Nickolas, et al.
Publicado: (2020)

TCT CONNECT-218 Transcatheter Therapies For COVID-19
por: Kipshidze, Nicholas, et al.
Publicado: (2020)

Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19
por: Kipshidze, Nicholas, et al.
Publicado: (2020)

Photodynamic and sonodynamic therapy of acute hypoxemic respiratory failure in patients with COVID-19
por: Kipshidze, Nicholas, et al.
Publicado: (2020)

COVID-19 Vaccines: Special Considerations for the Obese Population
por: Kipshidze, Nicholas, et al.
Publicado: (2021)

Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat
por: Kakabadze, Zurab, et al.
Publicado: (2022)

The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries
por: Duroseau, Brenice, et al.
Publicado: (2023)

Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury
por: Kakabadze, Zurab, et al.
Publicado: (2016)

Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?
por: Guler, Nil, et al.
Publicado: (2020)

Editorial: Thrombo-inflammation in cardiovascular disease and health
por: Jung, Richard G., et al.
Publicado: (2023)

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

First-in-Human Percutaneous Circumferential Annuloplasty for Secondary Tricuspid Regurgitation
por: Reddy, Vivek Y., et al.
Publicado: (2020)

Local drug delivery system for the treatment of tongue squamous cell carcinoma in rats
por: Kakabadze, Mariam Z., et al.
Publicado: (2022)

The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients
por: Allen, Madeline, et al.
Publicado: (2023)

Molecular Systems Network Predicts Sars-Cov-2 NSP3 and Orf6 Role in COVID-19 Related Thrombotic Events
por: Hussain, Mushtaq, et al.
Publicado: (2022)

Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery
por: Kou, Longfa, et al.
Publicado: (2020)

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism
por: O’Hara, Alexander, et al.
Publicado: (2023)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation
por: Odeh, Ameer, et al.
Publicado: (2022)

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin
por: Olson, Guy, et al.
Publicado: (2023)

Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation
por: Odeh, Ameer, et al.
Publicado: (2023)

Upregulation of Inflammatory Cytokines in Pulmonary Embolism Using Biochip-Array Profiling
por: Bontekoe, Emily, et al.
Publicado: (2021)

Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey
por: Kantarcioglu, Bulent, et al.
Publicado: (2021)

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis
por: Mehrotra, Siddharth, et al.
Publicado: (2022)

Giant g-factors and fully spin-polarized states in metamorphic short-period InAsSb/InSb superlattices
por: Jiang, Yuxuan, et al.
Publicado: (2022)

Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels
por: Jeske, Walter, et al.
Publicado: (2019)

Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Nanoparticles as delivery vehicles for antiviral therapeutic drugs
por: Maus, Alexander, et al.
Publicado: (2021)

Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
por: Leong, Ellenmae W. X., et al.
Publicado: (2022)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
por: Siddiqui, Fakiha, et al.
Publicado: (2022)

Extracellular Vesicles as Delivery Vehicles of Specific Cellular Cargo
por: Mir, Bilal, et al.
Publicado: (2020)

Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development
por: Liang, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b62ca2fbnk7i6e9l1gnutn7f4d